The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...

The president of the American College of Obstetricians and Gynecologists said the claims were "outlandish and unfounded" and will "only serve to incite fear." ...

On July 21, the US Food and Drug Administration (FDA) convened a 10-expert panel to determine whether women should be warned about the potential dangers to their baby if they take antidepressants like ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Pregnancy presents a unique ethical dilemma. The unborn child cannot give consent, and damage sustained in the womb can ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

The FDA is spreading lies about medications people need—and starting their attack by targeting pregnant women.

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

Medicaid and ACA, the homeless crisis, children's health, 'black box' drug warnings, nutrition and SNAP, maternity care, and more.

A House subcommittee will hold a hearing today covering safety lapses and improvements to be made to the organ donor system. In other news: the FDA's debate on antidepressant use during pregnancy; the ...